CORRECTION article

Front. Cell Dev. Biol., 11 April 2024

Sec. Cellular Biochemistry

Volume 12 - 2024 | https://doi.org/10.3389/fcell.2024.1403128

Corrigendum: Editorial: Metabolic modulation of cellular function

  • 1. Department of Neurology, The Anges Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  • 2. Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel

  • 3. Department of Genetic and Metabolic Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  • 4. Laminar Pharmaceuticals, Palma de Mallorca, Spain

  • 5. Department of Biology, University of the Balearic Islands, Palma de Mallorca, Spain

In the published article, there was an error in the Affiliation list. Instead of “1Hadassah Medical Center, Jerusalem, Israel, 2University of the Balearic Islands”, it should be:

1Department of Neurology, The Anges Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

2Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel

3Department of Genetic and Metabolic Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

4Laminar Pharmaceuticals, Palma de Mallorca, Spain

5Department of Biology, University of the Balearic Islands, Palma de Mallorca, Spain.”

In the published article there was an error in the Conflict of interest section. It was missing the mention of Laminar Pharmaceuticals. This should have been written as:

Statements

Conflict of interest

“Author PE was employed by Laminar Pharmaceuticals.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

metabolism, metabolic pathways, drug discovery, cell fate, metabolomics

Citation

Kakhlon O, Saada A and Escriba PV (2024) Corrigendum: Editorial: Metabolic modulation of cellular function. Front. Cell Dev. Biol. 12:1403128. doi: 10.3389/fcell.2024.1403128

Received

18 March 2024

Accepted

26 March 2024

Published

11 April 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

12 - 2024

Updates

Copyright

*Correspondence: Or Kakhlon,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics